Form 4: Encompass Health Director Leslye Katz Receives 74 Restricted Stock Units from Dividend Reinvestment

Encompass Health Corp. Director Leslye G. Katz was credited with 74 restricted stock units (RSUs) on July 15, 2025, as part of a dividend reinvestment program.

Summary

• Leslye G. Katz, a Director of Encompass Health Corp. (EHC), acquired 74 shares of Encompass Health Common Stock on July 15, 2025.
• This acquisition was an award of Restricted Stock Units (RSUs) at a price of $0, not a direct purchase.
• The RSUs were credited to her account in connection with common stock dividend payments, as per outstanding restricted stock unit award agreements.
• The number of RSUs was calculated based on the product of RSUs in her account on the dividend record date and the per share dividend, divided by the closing price on the dividend payment date.
• On July 15, 2025, Encompass Health paid a dividend of $0.17 per share, and the closing price of the common stock was $107.28.
• Following this transaction, Leslye G. Katz beneficially owns 47,679 shares of Encompass Health Common Stock.

Sentiment

Score: 6

Explanation: The transaction is a routine RSU award to a director, indicating continued alignment of interests and standard compensation practices. It is a neutral to slightly positive event as it increases insider ownership, albeit through a non-cash award.

Positives

• The acquisition of RSUs by a director indicates continued alignment of interests between management and shareholders through equity ownership.
• The RSU award is part of a routine dividend reinvestment process for non-employee directors, reflecting a standard compensation practice.

Negatives

• No specific negative points are indicated by this routine RSU award.

Risks

• No specific risks are mentioned in this Form 4 filing.

Future Outlook

This Form 4 filing details a past transaction and does not provide forward-looking statements or guidance regarding the company's future performance or strategic direction.

Industry Context

This Form 4 filing reports a routine insider transaction related to director compensation and dividend reinvestment. It does not provide broader industry trends or competitive analysis, as it is specific to an individual's equity holdings within Encompass Health Corp.

Comparison to Industry Standards

• This Form 4 filing is a standard disclosure of an insider transaction and does not contain information suitable for comparison to global benchmarks, specific comparable companies, projects, or results. The RSU award mechanism tied to dividends is a common practice for non-employee director compensation across various industries.

Related Party Transactions

• The acquisition of Restricted Stock Units by a director from the company is inherently a related party transaction, representing a form of compensation.

Stakeholder Impact

• Shareholders: The transaction increases the director's equity stake, aligning their interests with shareholders. It also reflects the company's ongoing dividend policy.
• Employees: No direct impact on employees is indicated.

Next Steps

• The document does not outline any specific future actions, events, or milestones for the company or the reporting person beyond the reported transaction.

Key Dates

Recommendation

Keywords

Encompass Health Corp, EHC, Form 4, SEC Filing, Restricted Stock Units, RSU, Director Compensation, Dividend Reinvestment, Insider Transaction, Equity Award